Antiparkinson agent
Showing 1 - 25 of 6,201
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)
Recruiting
- Late Life Depression
- +4 more
- L-Dopa
- Placebo
-
Nashville, TennesseeVanderbilt Psychiatric Hospital
Feb 23, 2022
Carious Lesion Trial in Islamabad (Adhesive resin restoration using Titania nanoparticle reinforced bonding agent, Adhesive
Enrolling by invitation
- Carious Lesion
- Adhesive resin restoration using Titania nanoparticle reinforced bonding agent
- Adhesive resin restoration without Titania nanoparticle incorporated bonding agen
-
Islamabad, PakistanSchool of Dentistry, Pakistan Institute of Medical Sciences
Feb 24, 2023
Malignant Tumor Trial in Chendu (EBV immunological agent)
Recruiting
- Malignant Tumor
- EBV immunological agent
-
Chendu, Sichuan, ChinaWest China Hospital
Jan 31, 2023
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Non-Motor Symptoms in Idiopathic Parkinson's Disease and
Completed
- Parkinson Disease
- inquiries
- (no location specified)
Mar 10, 2021
Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- ASP1948
- +2 more
-
New Haven, Connecticut
- +41 more
Jan 10, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1951, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
-
Tucson, Arizona
- +31 more
Jan 10, 2023
Intubation Complication Trial in Karachi (Intravenous morphine)
Completed
- Intubation Complication
- Intravenous morphine
-
Karachi, Sind, PakistanPNS Shifa Hospital
Oct 1, 2023
Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)
Not yet recruiting
- Light Chain (AL) Amyloidosis
- +2 more
- Venetoclax
- Dexamethasone Oral
- (no location specified)
Aug 16, 2023
Superficial Digital Flexor Tendonitis Trial in Zürich (Genipin)
Completed
- Superficial Digital Flexor Tendonitis
-
Zürich, ZH, SwitzerlandEquine surgery, Vetsuisse-Faculty, University of Zurich
Feb 22, 2023
To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
Not yet recruiting
- To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
- (no location specified)
Aug 29, 2023
Chronic Hepatitis B Trial in Seoul (Standard of care)
Active, not recruiting
- Chronic Hepatitis B
- Standard of care
-
Seoul, Korea, Republic of
- +3 more
Mar 29, 2023
Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer Trial in Austin, San Antonio, Fairfax (BDC-3042,
Recruiting
- Triple Negative Breast Cancer
- +5 more
-
Austin, Texas
- +2 more
Sep 19, 2023
Vestibular Schwannoma Trial in Rochester (Omega-3, Placebo)
Recruiting
- Vestibular Schwannoma
- Omega-3
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 11, 2022
Desmoid Tumor Trial in Palo Alto (Nirogacestat, Cryoablation)
Not yet recruiting
- Desmoid Tumor
- Nirogacestat
- Cryoablation
-
Palo Alto, CaliforniaStanford University
Jul 7, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Kafrelsheikh (Budesonide, Prednisone, Saline)
Completed
- Chronic Rhinosinusitis With Nasal Polyps
- Budesonide
- +2 more
-
Kafrelsheikh, EgyptKafrelsheikh University hospital
Jul 3, 2023
